Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/17/2005US20050257286 DNA sequence for root preferred gene expression in plants
11/17/2005US20050257285 Compositions and methods for the treatment of Pierce's disease
11/17/2005US20050257284 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
11/17/2005US20050257283 Transformed plants with enhanced prenylquinone biosynthesis
11/17/2005US20050257282 Plant centromere compositions
11/17/2005US20050257280 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide
11/17/2005US20050257279 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
11/17/2005US20050257278 Transgenic non-human animals expressing a truncated activin type II receptor
11/17/2005US20050257277 Regulation of transcription with a cis-acting ribozyme
11/17/2005US20050257276 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/17/2005US20050256815 Medical applications of adaptive learning systems using gene expression data
11/17/2005US20050256525 Dilation introducer for orthopedic surgery
11/17/2005US20050256304 Modified factor VIII
11/17/2005US20050256303 Having antibacterial activity, antioxidative effect, inflammation inhibitory effect, in vivo substance transporting action, and enzymatic activity, used as a drug administration carrier
11/17/2005US20050256302 Novel peptides having camp producing activity
11/17/2005US20050256299 Vaccines
11/17/2005US20050256283 Monomers containing polyoxyalkylenes and polymer supports therefrom
11/17/2005US20050256076 RNA interference modulators of hedgehog signaling and uses thereof
11/17/2005US20050256075 Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
11/17/2005US20050256073 Immunostimulatory viral RNA oligonucleotides
11/17/2005US20050256072 Dual functional oligonucleotides for use in repressing mutant gene expression
11/17/2005US20050256071 Inhibitor nucleic acids
11/17/2005US20050256068 Moderator of gene expression; using small nucleic acids
11/17/2005US20050256067 Method of preparing a treatment product, treatment product and a plasmid construct
11/17/2005US20050256057 Proline-specific endoprotease and tripeptidase digested polypeptide mixture comprising tripeptides for use in pharmaceuticals and nutraceuticals
11/17/2005US20050256052 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes
11/17/2005US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei
11/17/2005US20050256050 Vascular endothelial growth factor 2
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256044 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256043 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies
11/17/2005US20050256042 Methods of preventing and treating alimentary mucositis
11/17/2005US20050256041 polypeptides, polynucleotides encoding the polypeptides and antibodies, for detecting ligands, as well as agonists and antagonists, modulation of tumor growth, metastasis and immunology
11/17/2005US20050256039 Novel fibroblast growth factors and methods of use thereof
11/17/2005US20050256036 Gastrointestinal proliferative factor and uses thereof
11/17/2005US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/17/2005US20050255597 Transformation of cells with vector carrying transgenic virus
11/17/2005US20050255596 Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
11/17/2005US20050255595 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests
11/17/2005US20050255574 Proteins
11/17/2005US20050255573 An in vitro method of maintaining a mouse or human pluripotent cell in a pluripotent state by increasing expression of a gene that encodes a factor which acts intracellularly and maintainspluripotency, where the factor is a polypeptide of the sequence of SEQ ID NO: 4; cultures
11/17/2005US20050255571 Biocatalysts in chemical reactions, activity, stability and enantioselectivity; for the preparation of optically active compounds
11/17/2005US20050255567 Mutant glutamine synthetase and method for producing amino acids
11/17/2005US20050255559 Isolated nucleic acid molecule(s) encoding a human calcium sensitive potassium channel subunit protein designated beta2, encoded proteins, and uses thereof
11/17/2005US20050255558 Signal sequence polypeptides for diagnosis, prevention and treatment of metabolic disorders
11/17/2005US20050255557 Novel compounds
11/17/2005US20050255555 Monoclonal antibody specific to epidermal growth factor receptor for targeting tumors and treating cancer; tissue targeted therapy
11/17/2005US20050255554 Fusion peptides isolatable by phase transition
11/17/2005US20050255553 Mage C2 antigenic peptides and uses thereof
11/17/2005US20050255552 Antibody specificity transfer using minimal essential binding determinants
11/17/2005US20050255551 Methods and compositions relating to chimeric nicotinic receptor subunits
11/17/2005US20050255550 Suppression of xenotransplant rejection
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255548 Protein scaffolds for antibody mimics and other binding proteins
11/17/2005US20050255547 Hexamers of receptors, members of the tnf receptor family, their use in therapy and pharmaceutical compositions comprising the same
11/17/2005US20050255546 DNA coding for a polypeptide; a polymer conjugated drug with increased stability of the protein in vivo; stimulating the production of erythrocyte progenitor cells in culture in the presence of the polypeptide, or in vivo
11/17/2005US20050255545 Regulation of human hematopoietin receptor-like protein
11/17/2005US20050255542 Expressing a thioredoxin-fused membrane protein, particularly a G protein-coupled receptor, in a cell-free system that preferably contains a nonionic detergent
11/17/2005US20050255541 Method for hydrolysing carotenoids esters
11/17/2005US20050255531 Signal transduction
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255526 Anti-tag antibody chip for protein interaction analysis
11/17/2005US20050255520 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); specifically binds to polypeptide encoded by nucleic acid; labeled or conjugated to therapeutic agent; treatment of cardiovascular disorders
11/17/2005US20050255519 Reagents and methods useful for detecting diseases of the prostate
11/17/2005US20050255518 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
11/17/2005US20050255517 Methods and devices for multiplexing amplification reactions
11/17/2005US20050255513 Regulatable growth of filamentous fungi
11/17/2005US20050255501 Method for gene identification signature (GIS) analysis
11/17/2005US20050255500 Determining subcellular distribution of Disrupted-in Schizophrenia-1 (DISC1) protein in cells to predict susceptibility of an individual to schizophrenia, bipolar disorder, major depression or substance abuse; haplotypes
11/17/2005US20050255499 Process for discrimination of nucleic acid sequence variants
11/17/2005US20050255497 Gene for coding thermostable L-arabinose isomerase and method for producing the same
11/17/2005US20050255496 Ztnf12, a tumor necrosis factor
11/17/2005US20050255493 Molecular targeting of the IGF-1 receptor
11/17/2005US20050255489 nucleotide sequence encoding a polypeptide having N-acetylglucosaminyl transferase V activity called Vb, useful in in vitro enzymatic reactions of this enzyme and in recombinant host cells for the production of glycoproteins with more efficient and extensive glycosylation
11/17/2005US20050255487 Methods and compositions for selecting siRNA of improved functionality
11/17/2005US20050255480 A norovirus-permissive cell culture, including dendritic- and macrophage-lineage cells and macrophages having a deficiency in a cellular anti-viral pathway such as a STAT-1-dependent pathway, an interferon receptor-dependent pathway, or a PKR-dependent pathway infected with a norovirus
11/17/2005US20050255469 Human 5-ht7 receptor promoter sequence
11/17/2005US20050255468 Determination of the level of high risk HPV encoded gene-products such as e.g. HPV E2 and/or HPV E7 molecules in biological samples in the course of cytological testing procedures
11/17/2005US20050255464 Methods for the identification of peptidyl compounds interacting with extracellular target molecules
11/17/2005US20050255462 Screening library of compounds using plurality of bacteriophage displaying compound other than the polypeptide expressed by bacteriophage; heterologous nucleic acid tag is inserted into bacteriophage; assaying and decoding; drug screening; combinatorial chemistry; receptor binding assay
11/17/2005US20050255461 Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
11/17/2005US20050255457 Nucleic acids encoding mirafiori lettuce virus protein and utilization thereof
11/17/2005US20050255455 Eif4e gene mutations and potyvirus resistance
11/17/2005US20050255452 Using reporter fusions as tools in monitoring protein-protein interactions
11/17/2005US20050255445 Method for high throughput cell-based assays using versatile living microarrays
11/17/2005US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
11/17/2005US20050255124 HCV E1E2 vaccine compositions
11/17/2005US20050255123 Chimeric ebola virus envelopes and uses therefor
11/17/2005US20050255115 T-cell surface glycoprotein specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy
11/17/2005US20050255113 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
11/17/2005US20050255110 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/17/2005US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes
11/17/2005US20050255094 Mitogen-activated protein kinase kinase MEK6 and methods of use therefor
11/17/2005US20050255093 treating nervous system disorders induced by stroke or injury, injured by trauma to reduce oxidative stress, administering a conjugate of antioxidant enzyme and a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain; tissue-targeted therapy
11/17/2005US20050255089 adeno-associated virus 5 (AAV5) specific polynucleotides, that codes for an AAV5 specific proteins; delivering polynucleotides to cells using the AAV5 vectors and particles
11/17/2005US20050255088 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer
11/17/2005US20050255087 Adeno-associated virus vectors
11/17/2005US20050255086 Adeno-associated viral vector comprising short interfering RNA for use in the treatment of nervous system disorders; tissue engineering and gene therapy; tissue targeted therapy
1 ... 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 ... 4023